Screening of PotentialAntiviral Compounds - Assessing Efficacies Against Dengue Virus

Simple item page
dc.contributor.authorOlanrewaju, Adeyemi A.
dc.contributor.authorEsan, Taiwo
dc.date.accessioned2024-04-11T18:45:11Z
dc.date.available2024-04-11T18:45:11Z
dc.date.issued2024-03
dc.description.abstractEpidemiology Dengue viruses (DENV) are spread to people through the bite of an infected Aedes species (Ae. Aegypti or Ae. albopictus)mosquito. Approximately, more than 3 billion people live in areas with high risk of dengue. It is the leading cause of illness in areas with risk vector borne disease (CDC, 2023). Genome DENV is a member of the Flavivirus genus of single-stranded positive-sense RNA viruses that causes severe generalized diseases in humans. There are four DENV serotypes (1, 2, 3 and 4), with type 2 and 3 being the most virulent forms (Vicente et al. 2016). Structure Mature DENV particles have a diameter of approximately 500nm. The surface is made up of a lipid bilayer which incorporate two transmembrane viral proteins to form a glycoprotein shell. The core contains the nucleocapsid formed by a viral RNA genome complex with capsid protein. The glycoprotein shell has 180 copies of envelope (E) and membrane protein (M or prM). The capsid (C) protein interacts with the viral RNA genome during assembly of the virus (Murugesan and Manoharan 2019).
dc.description.departmentMedical Laboratory Science
dc.formatImage
dc.format.extent1 page
dc.format.medium1 file (.pdf)
dc.identifier.citationOlanrewaju, A., & Esan, T. (2024). Screening of potential antiviral compounds - Assessing efficacies against dengue virus. Poster presented at the Health Scholar Showcase, Translational Health Research Center, San Marcos, Texas.
dc.identifier.urihttps://hdl.handle.net/10877/18438
dc.language.isoen
dc.sourceHealth Scholar Showcase, 2024, Texas State University Translational Health Science Center, San Marcos, Texas, United States.
dc.subjectantiviral
dc.subjectdengue virus
dc.titleScreening of PotentialAntiviral Compounds - Assessing Efficacies Against Dengue Virus
dc.typePoster

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Olanrewaju, Adeyemi Screening of  Potential Antiviral Compounds - Assessing Efficacies Against Dengue Virus.pdf
Size:
1.91 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Health Scholar Showcase